Division of Cardiothoracic Surgery, Department of Surgery, Columbia University Medical Center, New York, New York 10032, USA.
Ann Thorac Surg. 2011 Jun;91(6):1763-8; discussion 1769. doi: 10.1016/j.athoracsur.2011.03.002.
Extracorporeal membrane oxygenation (ECMO) provides supplementary oxygenation and carbon dioxide removal for selected patients on mechanical ventilatory support. Venovenous ECMO is traditionally established by dual cannulation of the internal jugular and femoral veins. We report our institutional experience using single-site, dual-lumen cannula for venovenous ECMO as an alternative to the 2-catheter approach. This approach minimizes recirculation and avoids use of the femoral site, which confers potential advantages.
This is a retrospective review of a single institution's experience with a new bicaval dual lumen ECMO cannula. During a 19-month period, 27 consecutive patients were placed on ECMO using this catheter inserted through the right internal jugular vein.
Single-site venovenous ECMO support was uneventfully initiated in 26 of the 27 patients (median age, 42 years; interquartile range, 31 to 58 years) and achieved full flows and adequate gas exchange. Median ventilator days before ECMO was 1 day (interquartile range, 0.25 to 3.5 days). The median duration of ECMO support was 9 days (interquartile range, 5.5 to 11.5 days). Decannulation was achieved in 70% of the patients and extubation in 59%. Two were bridged to lung transplantation and are still alive. The overall survival and hospital discharge rate was 56%. There was no device failure or in-cannula thrombosis. One superior vena cava injury occurred, and one cannula required repositioning.
Single-site venovenous ECMO has advantages compared with traditional venovenous ECMO. Using image guidance, the cannula can reliably be used in prolonged venovenous ECMO cases.
体外膜肺氧合(ECMO)为接受机械通气支持的特定患者提供补充氧合和二氧化碳去除。传统上,通过双腔颈内静脉和股静脉插管建立静脉-静脉 ECMO。我们报告了使用单部位、双腔管进行静脉-静脉 ECMO 的机构经验,作为双导管方法的替代方法。这种方法最大限度地减少了再循环,并避免使用股静脉部位,从而带来潜在优势。
这是对使用新的双腔双腔 ECMO 套管进行单中心经验的回顾性分析。在 19 个月期间,27 例连续患者通过右颈内静脉插入该导管进行 ECMO。
27 例患者中的 26 例(中位年龄 42 岁;四分位距 31 至 58 岁)成功地进行了单部位静脉-静脉 ECMO 支持,实现了全流量和充足的气体交换。在 ECMO 前的中位呼吸机天数为 1 天(四分位距 0.25 至 3.5 天)。ECMO 支持的中位时间为 9 天(四分位距 5.5 至 11.5 天)。70%的患者实现了脱机,59%的患者成功拔管。有 2 例患者桥接到肺移植,并且仍然存活。总体生存率和出院率为 56%。没有设备故障或套管内血栓形成。发生 1 例上腔静脉损伤,1 例套管需要重新定位。
与传统的静脉-静脉 ECMO 相比,单部位静脉-静脉 ECMO 具有优势。使用影像引导,套管可在长时间的静脉-静脉 ECMO 病例中可靠使用。